In the present study, we propose a novel mechanism for the PPARα-medicated inhibition of astrocyte inflammation activation by preserving the lysosome function and by restoring autophagic flux through the subsequent lysosomal degradation of autophagic vesicles after transient brain ischemia. Here, PPARA is linked to brain ischemia.